Research Publications

  1. Therapies from Fucoidan: New developments. Marine Drugs, 2019
    2. A comprehensive review exploring recent global fucoidan research and noting the increased use of fucoidans in commercially available supplements and topical treatments. Full Article Link: https://www.mdpi.com/1660-3397/17/10/571
  2. Fucoidan and cancer: a multifunctional molecule with anti-tumor potential. Marine Drugs. 2015
    3. This review discusses the mechanisms by which fucoidan retards tumor development, eradicates tumor cells and synergizes with anti-cancer chemotherapeutic agents. Full Article Link: https://www.mdpi.com/1660-3397/13/4/2327
  3. Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy. Marine Drugs, 2023
    4. This review focuses on current progress and understanding of the immunopotentiation activity of various fucoidans, emphasizing their relevance to cancer immunotherapy. Full Article Link: https://www.mdpi.com/1660-3397/21/2/128
  4. Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus. Mol Clin Oncol. 2020
    5. A prospective, open-label clinical study was conducted on cancer survivors treated with fucoidan via oral administration; 11 cancer survivors with a performance status of 0 or 1 participated and consumed 3 g of fucoidan for 6 months. Full Article Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6888040/
  5. Fucoidan-New Principle Prevention and Treatment of Diabetes. Journal of Pharmacy and Pharmacology, 2019.
    6. This review considered the possibility of using fucoidan as sulfated polysaccharide of brown algae to maintain glucose homeostasis by reducing the rate of absorption of glucose from the intestine and increasing its utilization by muscle fibers as a nutraceutical for patients with diabetes mellitus. Full ArticleLink: https://www.academia.edu/39154872/Fucoidan_New_Principle_Prevention_and_Treatment_of_Diabetes
  6. The seasonal variation of fucoidan within three species of brown macroalgae, Algal Research, 2017. 
    7. The variation of sulphate and fucose content has been studied in more depth: these are seen to vary in line with each other and follow an inverse trend to the total fucoidan content. Fucoidan content has been shown to vary over the year, with the highest content in the autumn. Full ArticleLink: https://www.sciencedirect.com/science/article/pii/S2211926416305604
  7. Fucoidan: Structure and Bioactivity
    8. This review summarizes the research progress on the structure and bioactivity of fucoidan and the relationships between structure and bioactivity. Full ArticleLink: https://pmc.ncbi.nlm.nih.gov/articles/PMC6245444/
  8. Fucoidan as a therapeutic agent for ulcerative colitis: mechanisms of action and modulation of the gut microbiota
    9. This review underscores FCD’s potential as a functional food or adjuvant therapy for UC, while advocating for rigorous clinical validation to bridge translational gaps, Enrichment of SCFAs-producing taxa and suppression of pathobionts (Escherichia coli, Candida albicans), mediated through prebiotic fermentation. Full ArticleLink: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2025.1626614/full
  9. The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations. Cancer Cell Int. 2020
    10. This paper reviews the mechanism by which fucoidan can eliminate tumor cells, delay tumor growth and synergize with anticancer chemotherapy drugs in vitro, in vivo and in clinical trials. Full ArticleLink: https://pmc.ncbi.nlm.nih.gov/articles/PMC7206694/
  10. Anti-angiogenic activity and mechanism of fucoidan from brown algae, Sargassum Naozhouense mediated by intracellular antioxidation, International Journal of Biological Macromolecules, 2025.
    11. In this study SNF (Sargassum Naozhouense fucoidan) was extracted by acid extraction method, and its relative molecular weight was determined to be 631.40 kDa. Full ArticleLink: https://www.sciencedirect.com/science/article/abs/pii/S0141813024101298
  11. Biological Activities of Fucoidan and the Factors Mediating Its Therapeutic Effects: A Review of Recent Studies. Marine Drugs. 2019.
    12. This review focuses on the progress in our understanding of the biological activities of fucoidan, highlighting its benefits for the treatment of human disease. Full ArticleLink: https://pmc.ncbi.nlm.nih.gov/articles/PMC6471298/
  12. Fucoidans from the brown seaweeds Undaria pinnatifida and Fucus vesiculosus as inhibitors of coagulant and phospholipase A2 activities of pit viper Lachesis muta venom and purified enzymes. Journal of Applied Phycology, 2026.
    13. An in vitro study exploring the potential inhibitory effects of fucoidans against venom from the pit viper Lachesis muta. Full Article Link: https://link.springer.com/epdf/10.1007/s10811-026-03838-4?sharing_token=h4SdvmiKFVt_96CkgC5Drfe4RwlQNchNByi7wbcMAY5pwZjWpPQq8-nm2sl3ecyn5YKEQfjBunfU9RsQKIchkEYjeudEOY7VW01ZrwLJyKfIDb5Y4iWoX297uUvOVaiEyJjy_cvjWHPZfPmbdZpQPs7Z4RjVBWdcU8Kcdt4CYOo%3D
  13. Fucoidan Characterization: Determination of Purity and Physicochemical and Chemical Properties. Marine Drugs. 2020
    14. The current article highlights the different spectrometric and nonspectrometric methods applied for the characterization of native fucoidans, including degree of purity, sugar monomeric composition, sulfation pattern and content, molecular mass, and glycosidic linkages. Full Article Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC7699409/
  14. Harnessing marine sulfated polysaccharides to inhibit norovirus: from seaweed to solution. Microbiology Spectrum, 2026.
    15. An in vitro study exploring the ability of polysaccharides, including fucoidans, to inhibit norovirus virus-like particles binding to histo-blood group antigens in human saliva. Full Article Link: https://journals.asm.org/doi/10.1128/spectrum.02445-25
  15. Fucoidan/bis-MPA-based dendrimer nanoparticles with intrinsic anti-angiogenic activity for oncology applications. RSC Pharmaceutics, 2026.
    16. An in vitro study screened fucoidans from the seaweeds Undaria pinnatifida and Fucus vesiculosus for anti-angiogenic activity prior to incorporating the best candidates into nanoparticles. Full Article Link: https://www.marinova.com.au/quarterly-news/exploring-cancer-nanomedicine/
  16. Investigating fucoidan blend supplementation and resistance training in humans: a parallel randomised controlled design. Scientific Reports, 2025.
    17. This clinical study investigated the effects of fucoidan supplementation in healthy adults undertaking a resistance training program, finding significant increases in peak power, relative peak power and lean body mass. Full Article Link: https://www.nature.com/articles/s41598-025-24066-9
  17. Anti-Inflammatory and neuroprotective effects of Undaria pinnatifida fucoidan. Marine Drugs, 2025.
    18. This review paper summarises research exploring Undaria pinnatifida fucoidan as a versatile marine agent with therapeutic relevance for inflammatory and neurodegenerative diseases. It outlines future research directions toward potential clinical translation. Full Article Link: https://www.mdpi.com/1660-3397/23/9/350
  18. Undaria pinnatifida fucoidan enhances gut microbiome, butyrate production, and exerts anti-inflammatory effects in an in vitro short-term SHIME® coupled to a Caco-2/THP-1 co-culture model. Marine Drugs, 2025.
    19. A validated gut model showed that Undaria pinnatifida fucoidan supplementation may provide significant gut health benefits. Full Article Link: https://www.mdpi.com/1660-3397/23/6/242   
  19. Neuroprotective and anti-inflammatory activity of Undaria pinnatifida fucoidan in vivo – A proteomic investigation. Marine Drugs, 2025.
    20. Undaria pinnatifida fucoidan was shown to significantly reduce the expression of pro-inflammatory cytokines and lower plasma cytokines in mice fed a high fat diet. Proteomic analysis showed that fucoidan modulated proteins involved in oxidative stress, neuroinflammation, neurotransmitter regulation and endoplasmic reticulum stress. Full Article Link: https://www.mdpi.com/1660-3397/23/5/189   
  20. The impact of fucoidan extracts on heat-stress-induced loss of in vitro fast-twitch muscle function in mice. Muscles, 2025.
    21. Fucus vesiculosus fucoidan was identified as a potential preventative strategy to protect against heat-induced loss of muscle strength in fast-twitch muscles. Full Article Link: https://www.mdpi.com/2813-0413/4/1/6#:~:text=In%20the%20present%20study%2C%20we,ROS%20production%20to%20levels%20equivalent
  21. Fucoidan ameliorates testosterone-induced benign prostatic hyperplasia (BPH) in rats, Research and Reports in Urology, 2024.
    22. Undaria pinnatifida fucoidan was shown to significantly reduce testosterone-induced BPH symptoms in rats. Full Article Link: https://www.dovepress.com/articles.php?article_id=96844   
  22. Fucoidan from Undaria pinnatifida enhances exercise performance and increases the abundance of beneficial gut bacteria in mice, Marine Drugs, 2024.
    23. Fucoidan supplementation was shown to enhance exercise performance, improve muscle function, and positively modulate gut microbiome in mice, regardless of diet. Full Article Link: https://www.mdpi.com/1660-3397/22/11/485
  23. Effect of seaweed-derived fucoidans from Undaria pinnatifida and Fucus vesiculosus on coagulant, proteolytic, and phospholipase A2 activities of snake Bothrops jararaca, B. jararacussu, and B. neuwiedi venom, Toxins, 2024.
    24. An in vitro study exploring the potential of high purity fucoidan to block toxicity effects of snake venom. Full Article Link: https://www.mdpi.com/2072-6651/16/4/188
  24. From Tasmania to the world: long and strong traditions in seaweed use, research, and development, Marina Botanica, 2023
    25. An overview of the seaweed industry in Tasmania, Australia. Full Article Link: https://www.degruyter.com/document/doi/10.1515/bot-2022-0061/html
  25. Expert perceptions of seaweed farming for sustainable development, Journal of Cleaner Production, 2022
    26. An overview of the possible opportunities and threats that large-scale seaweed farming presents to sustainability. Full Article Link: https://www.sciencedirect.com/science/article/pii/S0959652622026403?via%3Dihub
  26. Fucoidan from Fucus vesiculosus can inhibit human norovirus replication by enhancing the host innate immune response, Journal of Functional Foods, 2022
    27. High purity fucoidan was shown to inhibit norovirus replication, a leading cause of gastroenteritis, by enhancing innate immune response. Full Article Link: https://www.sciencedirect.com/science/article/pii/S1756464622002195
  27. Fucoidan independently enhances activity in human immune cells and has a cytostatic effect on prostate cancer cells in the presence of Nivolumab, Marine Drugs, 2022
    28. High purity fucoidan compounds activated human PBMCs and reduced prostate cancer cell numbers in combination with CD3 and Nivolumab. Full Article Link: https://www.mdpi.com/1660-3397/20/1/12
  28. Anti-inflammatory activity of fucoidan extracts in vitro, Marine Drugs, 2021
    29. Fucoidan extracts from multiple seaweed species showed significant anti-inflammatory effects. Full Article Link: https://www.mdpi.com/1660-3397/19/12/702/htm
  29. Modulation of gene expression in a sterile atopic dermatitis model and inhibition of Staphylococcus aureus adhesion by fucoidan, Dermatopathology, 2021
    30. Fucoidan extracts may be useful topical agents to assist in the future management of atopic dermatitis. Full Article Link: https://www.mdpi.com/2296-3529/8/2/12
  30. Oral fucoidan improves muscle size and strength in mice, Physiological Reports, 2021
    31. Findings suggest an important influence of fucoidans on skeletal muscle physiology. Full Article Link: https://physoc.onlinelibrary.wiley.com/doi/10.14814/phy2.14730
  31. Fucoidan and lung function: Value in viral infection, Marine Drugs, 2021
    32. A review paper discussing recent research into the potential for fucoidans in limiting lung damage that is often caused by respiratory viral infections. Full Article Link: https://www.mdpi.com/1660-3397/19/1/4
  32. Incorporation of FGF-2 into pharmaceutical grade fucoidan/chitosan polyelectrolyte multilayers, Marine Drugs, 2020
    33. Fucoidans are highlighted as promising candidates for the development of new materials for use in the medical device sector. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/33114688/
  33. Fucoidan supplementation restores fecal lysozyme concentrations in high-performance athletes: A pilot study, Marine Drugs, 2020
    34. Fucoidans have been shown to restore the secretion of anti-microbial peptides and contribute to the regulation of mucosal immune health in elite athletes. Full Article Link: https://www.mdpi.com/1660-3397/18/8/412
  34. Oral fucoidan attenuates lung pathology and clinical signs in a severe influenza A mouse model, Marine Drugs, 2020
    35. Australian and UK researchers have demonstrated that certain fucoidans are effective in significantly reducing clinical symptoms and lung damage in a severe Influenza A H1N1 model. Full Article Link: https://www.mdpi.com/1660-3397/18/5/246
  35. MicroRNA expression after ingestion of fucoidan; A clinical study. Marine Drugs, 2020
    36. An Australian clinical study, co-authored by members of Marinova’s research team, reveals that a fucoidan extract from the seaweed Undaria pinnatifida influences over 30 different biological pathways and processes. Full Article Link: https://www.mdpi.com/1660-3397/18/3/143
  36. Lysozyme uptake into pharmaceutical grade fucoidan/chitosan polyelectrolyte multilayers under physiological conditions. Journal of Colloid and Interface Science, 2020
    37. An examination of polyelectrolyte multilayers (PEMs) demonstrating that fucoidans are promising candidates for the development of new materials in the medical device sector. Full Article Link: https://www.sciencedirect.com/science/article/abs/pii/S0021979720300321
  37. The manufacture, characterization, and uses of fucoidans from macroalgae, 2019
    38. A comprehensive chapter prepared by Marinova’s research team and published in Enzymatic technologies for marine polysaccharides edited by Antonio Trincone. Full Article Link: https://www.taylorfrancis.com/books/9780429058653/chapters/10.1201/9780429058653-3
  38. Pathway analysis of fucoidan activity using a yeast gene deletion library screen. Marine Drugs, 2019
    39. Outcomes of the first study to screen fucoidans against a gene library to investigate all possible pathways of action. Fucoidans were shown to work selectively against cancer cells but not against normal, healthy cells that were used as a control. Full Article Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356313/
  39. Odd-even effects on hydration of natural polyelectrolyte multilayers: An in situ synchrotron FTIR microspectroscopy study. Journal of Colloid and Interface Science, 2019
    40. Odd-even effects in polysaccharide polyelectrolyte multilayers influence their hydration content and the chemical environment of the water within them. Full Article Link: https://www.sciencedirect.com/science/article/abs/pii/S002197971930709X
  40. Comparative study on neuroprotective activities of fucoidans from Fucus vesiculosus and Undaria pinnatifida. International Journal of Biological Macromolecules, 2019
    41. This study investigated the neuroprotective activities of five different fucoidan samples with different chemical compositions prepared from Fucus vesiculosus (FE, FF, and S) and Undaria pinnatifida (UE and UF) to determine if they reduced aggregation or cytotoxicity of Aβ1–42 in neuronal PC-12 cells. Full Article Link: https://www.sciencedirect.com/science/article/abs/pii/S0141813018340054
  41. The effect of Undaria pinnatifida fucoidan on the pharmacokinetics of letrozole and tamoxifen in patients with breast cancer. Integr Cancer Ther. 2018
    42. No significant changes in steady-state plasma concentrations of letrozole, tamoxifen, or tamoxifen metabolites were detected after co-administration with fucoidans. In addition, no adverse effects of fucoidans were reported, and toxicity monitoring showed no significant differences in all parameters measured over the study period. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/28008779/
  42. Electrochemical behaviour at a liquid-organogel microinterface array of fucoidan extracted from algae. Analyst, 2017
    43. An assessment of the electrochemical behaviour of fucoidans extracted from two algal species, Undaria pinnatifida and Fucus vesiculosus. Full Article Link: https://pubs.rsc.org/en/content/articlelanding/2017/an/c7an00761b#!divAbstract
  43. The influence of polyanion molecular weight on polyelectrolyte multilayers at surfaces: protein adsorption and protein–polysaccharide complexation/stripping on natural polysaccharide films on solid supports. Physical Chemistry Chemical Physics, 2017
    44. Two different fucoidan polymers were used to create substrates for protein adsorption studies. Full Article Link: https://pubs.rsc.org/en/content/articlelanding/2017/cp/c7cp02599h#!divAbstract
  44. Effects of fucoidan from Fucus vesiculosus in reducing symptoms of osteoarthritis: a randomized placebo-controlled trial. Biologics, 2016
    45. A clinical investigation demonstrating that a Fucus vesiculosus fucoidan extract was safe and well tolerated. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/27307702/
  45. Quantitative determination of fucoidan using polyion-sensitive membrane electrodes. Analytica Chimica Acta, 2015
    46. The use of polyanion and polycation-sensitive membrane electrodes to detect five different preparations of fucoidan is described. Full Article Link: https://europepmc.org/article/med/26002205
  46. In situ ATR FTIR spectroscopic study of the formation and hydration of a fucoidan/chitosan polyelectrolyte multilayer. Langmuir, 2015
    47. The formation of fucoidan/chitosan-based polyelectrolyte multilayers (PEMs) has been studied with in situ Fourier transform infrared (FTIR) spectroscopy. Full Article Link: https://pubs.acs.org/doi/10.1021/acs.langmuir.5b01812
  47. Therapies from fucoidan: An update. Marine Drugs, 2015
    48. An updated review discussing existing research findings on fucoidans. This review discusses the main bioactivities and application areas of fucoidans, as well as characterisation, extraction and detection methods for fucoidan compounds. Full Article Link: https://www.ncbi.nlm.nih.gov/pubmed/26389927
  48. Fucoidan extracts ameliorate acute colitis. PLOS ONE, 2015
    49. This research paper highlights the benefits of oral fucoidan in a mouse model of acute colitis. Cumulative histological disease scores for the distal colon and weight loss – a common and often undesirable side effect of colitis – were significantly reduced. Full Article Link: https://www.ncbi.nlm.nih.gov/pubmed/26083103
  49. Fucoidans disrupt adherence of Helicobacter pylori to AGS cells in vitro. Evidence Based Complementary and Alternative Medicine, 2015
    50. The in vitro studies discussed in this paper show fucoidan extracts are extremely effective at dislodging H. pylori from infected human gastric cells. The study also shows fucoidan extracts inhibit human gastric cancer cells in vitro. Full Article Link: https://www.ncbi.nlm.nih.gov/pubmed/26604968
  50. Topical benefits of two fucoidan-rich extracts from marine macroalgae. Cosmetics, 2015
    51. This comprehensive research paper discusses a variety of clinical and in vitro studies that attest to the profound cosmetic bioactivity of high purity fucoidans. These qualities include anti-ageing, protecting and soothing following UV exposure and skin brightening. Full Article Link: http://www.mdpi.com/2079-9284/2/2/66
  51. Tuning polyelectrolyte multilayer structure by exploiting natural variation in fucoidan chemistry. Soft Matter, 2015
    52. Distinct differences were observed between multilayers formed with two different fucoidans from two different seaweed species. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/25599229/
  52. A fucose containing polymer-rich fraction from the brown alga Ascophyllum nodosum mediates lifespan increase and thermal-tolerance in Caenorhabditis elegans, by differential effects on gene and protein expression. Food Funct. 2015
    53. An Ascophyllum nodosum fucose-containing polymer (FCP) significantly improved the life span and tolerance against thermally induced stress in Caenorhabditis elegans. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/24323434/
  53. Therapies from fucoidan; Multifunctional marine polymers. Marine Drugs, 2011
    54. A comprehensive review providing an elaborate guide on fucoidan research undertaken between 2000 and 2010. This review paper provides a foundation for the subsequent review papers published in 2015 and 2019. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/22072995/
  54. Formation of an adherent hematopoietic expansion culture using fucoidan. Annals of Hematology, 2011
    55. Characterizing the effect on hematopoietic cell culture of fucoidans. Full Article Link: https://www.researchgate.net/publication/49842527_Formation_of_an_adherent_hematopoietic_expansion_culture_using_fucoidan
  55. A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex. Biologics, 2011
    56. This article provides clinical evidence to confirm the safety of oral fucoidan administration. Fucoidans significantly increased cytotoxic T cells and phagocytic capacity in monocytes, as well as significantly decreasing levels of inflammatory cytokine Interleukin-6. Full Article Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044793/
  56. A combined phase I and II open-label study on the effects of seaweed extract nutrient complex on osteoarthritis. Biologics, 2010
    57. Osteoarthritis symptoms decreased in a dose-dependent manner, when human subjects suffering from clinical diagnosed osteoarthritis were supplemented with oral fucoidan extracts. This study also confirms the safety of oral fucoidans consumed at a high dose over a 12 week period. Full Article Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846142/
  57. Pilot clinical study to evaluate the anticoagulant activity of fucoidan. Blood Coagul Fibrinolysis, 2009
    58. This pilot clinical trial aimed to assess the safety and clinical effects of fucoidans ingestion on hemostasis. Full Article Link: https://journals.lww.com/bloodcoagulation/Abstract/2009/10000/Pilot_clinical_study_to_evaluate_the_anticoagulant.22.aspx
  58. Fucoidan ingestion increases the expression of CXCR4 on human CD34+ cells. Experimental Hematology, 2007
    59. This research paper elaborates on the ability of fucoidans to increase stem cell populations. The clinical trial found oral administration of a fucoidan extract from Undaria pinnatifida significantly increased the CXCR4 hemopoietic stem cell population, from 45% to 90% after only 12 days. Full Article Link: https://www.ncbi.nlm.nih.gov/pubmed/17533053
  59. Macroalgal fucoidan extracts: A new opportunity for marine cosmetics. Cosmetics and Toiletries, 2007
    60. An exploration of the bioactivity and historical applications of macroalgae with a particular focus on fucoidans. Full Article Link: https://www.cosmeticsandtoiletries.com/research/techtransfer/8855547.html
  60. Marine algae and polysaccharides with therapeutic applications, 2007
    61. A chapter within Marine nutraceuticals and functional foods (pp.345-366) published by CRC Press Full Article Link: https://www.researchgate.net/publication/299630236_Marine_Algae_and_Polysaccharides_with_Therapeutic_Applications
  61. A quantitative method to detect fucoidan in human plasma using a novel antibody. Methods Find Exp Clin Pharmacol, 2005
    62. An antibody-based method to assess plasma uptake of a proprietary Undaria-derived fucoidan galactofucan sulfate (GFS(TM)) after oral ingestion by human volunteers. Full Article Link: https://pubmed.ncbi.nlm.nih.gov/16395421/   
  62. Antiviral activity of Undaria pinnatifida against herpes simplex virus. Phytotherapy Research, 2004
    63. This paper presents in vitro studies on the activity of fucoidans towards various clinical strains of the herpes simplex virus. A Undaria pinnatifida fucoidan extract was found to exhibit excellent anti-viral activity, through the inhibition of viral binding and entry to host cells. Full Article Link: https://www.ncbi.nlm.nih.gov/pubmed/15305315
  63. Brown marine algae: A survey of therapeutic potentials. Alternative and Complementary Therapies, 2003
    64. An overview of the potential therapeutic benefits of fucoidans. Full Article Link: https://www.liebertpub.com/doi/pdf/10.1089/10762800360520767

Fucoidan AI Assistant

✕
Hello! I am Fucoidan AI. I provide research-backed info on Fucoidan studies. How can I help you today?
AI is thinking...
Engineered by Syed Ahmar Ali

Looking for High-Purity Fucoidan?

NatureMedic™ Fucoidan is trusted by integrative professionals worldwide.

Learn More at NMfucoidan.com

Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Fucoidan Research does not diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before beginning any new supplement regimen, especially if you are currently undergoing medical treatment.

Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Fucoidan Research does not diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before beginning any new supplement regimen, especially if you are currently undergoing medical treatment.

I Understand